Insider · CIK 0001835458
Mark Ragosa
cfoofficer
Files at KNSA (Kiniksa Pharmaceuticals International, plc). First filing Dec 5, 2024, latest Mar 11, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 14
$0 bought, $12M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KNSA: Kiniksa Pharmaceuticals International, plc
KNSAOct 9, 2026 · close 79.78
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | Kiniksa Pharmaceuticals International, plc | $1.7M 36,722 shares | -75% | +151% from low-2% from high | |
| 37Weak | Kiniksa Pharmaceuticals International, plc | $772k 17,845 shares | -60% | +138% from low-1% from high | |
| 30Weak | Kiniksa Pharmaceuticals International, plc | $503k 12,000 shares | -39% | +130% from low-4% from high | |
| 47Moderate | Kiniksa Pharmaceuticals International, plc | $1.8M 42,841 shares | -58% | +129% from low-3% from high | |
| 34Weak | Kiniksa Pharmaceuticals International, plc | $815k 19,900 shares | -39% | +123% from low-0% from high | |
| 2Weak | Kiniksa Pharmaceuticals International, plc | $4,100 100 shares | -0% | +117% from low-3% from high | |
| 32Weak | Kiniksa Pharmaceuticals International, plc | $621k 18,889 shares | -41% | +81% from low0% from high | |
| 30Weak | Kiniksa Pharmaceuticals International, plc | $527k 18,299 shares | -40% | +60% from low0% from high | |
| 47Moderate | Kiniksa Pharmaceuticals International, plc | $2.3M 88,395 shares | -128% | +42% from low-6% from high | |
| 27Weak | Kiniksa Pharmaceuticals International, plc | $368k 15,944 shares | -41% | - | |
| 39Weak | Kiniksa Pharmaceuticals International, plc | $470k 20,343 shares | -58% | - | |
| 44Moderate | Kiniksa Pharmaceuticals International, plc | $809k 36,372 shares | -61% | - | |
| 41Moderate | Kiniksa Pharmaceuticals International, plc | $594k 27,829 shares | -87% | - | |
| 26Weak | Kiniksa Pharmaceuticals International, plc | $323k 15,116 shares | -47% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +2,694 | - | - | 18,848 | 39 d ago |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +1,750 | - | - | 20,598 | 39 d ago |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +1,591 | - | - | 22,189 | 39 d ago |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +3,069 | - | - | 25,258 | 39 d ago |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | FTax withholding Class A Ordinary Share | -4,404 | $79.28 | $349k | 20,854 | 39 d ago |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Restricted Share Unitderivative | +7,800 | $0.00 | $0 | 7,800 | 39 d ago |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Share Optionderivative | +31,150 | $0.00 | $0 | 31,150 | 39 d ago |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -3,069 | $0.00 | $0 | 9,206 | 39 d ago |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -1,591 | $0.00 | $0 | 3,182 | 39 d ago |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -1,750 | $0.00 | $0 | 1,750 | 39 d ago |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -2,694 | $0.00 | $0 | 0 | 39 d ago |
| Mar 9, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +2,036 | $22.89 | $47k | 14,122 | Mar 11, 2026 |
| Mar 9, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +10,513 | $17.76 | $187k | 24,635 | Mar 11, 2026 |
| Mar 9, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +13,813 | $18.06 | $249k | 38,448 | Mar 11, 2026 |
| Mar 9, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +10,360 | $26.74 | $277k | 48,808 | Mar 11, 2026 |
| Mar 9, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -17,981 | $45.58 | $820k | 30,827 | Mar 11, 2026 |
| Mar 9, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -18,741 | $46.24 | $867k | 12,086 | Mar 11, 2026 |
| Mar 9, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -2,036 | $0.00 | $0 | 0 | Mar 11, 2026 |
| Mar 9, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -10,513 | $0.00 | $0 | 18,396 | Mar 11, 2026 |
| Mar 9, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -13,813 | $0.00 | $0 | 19,337 | Mar 11, 2026 |
| Mar 9, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -10,360 | $0.00 | $0 | 22,790 | Mar 11, 2026 |
| Feb 9, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +8,374 | $12.97 | $109k | 27,460 | Feb 11, 2026 |
| Feb 9, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +2,471 | $16.90 | $42k | 29,931 | Feb 11, 2026 |
| Feb 9, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -9,114 | $42.85 | $391k | 20,817 | Feb 11, 2026 |
| Feb 9, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -8,731 | $43.72 | $382k | 12,086 | Feb 11, 2026 |
| Feb 9, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -8,374 | $0.00 | $0 | 0 | Feb 11, 2026 |
| Feb 9, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -2,471 | $0.00 | $0 | 0 | Feb 11, 2026 |
| Jan 8, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -12,000 | $41.89 | $503k | 19,086 | Jan 9, 2026 |
| Dec 8, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +16,164 | $11.10 | $179k | 47,250 | Dec 10, 2025 |
| Dec 8, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +16,165 | $11.97 | $193k | 63,415 | Dec 10, 2025 |
| Dec 8, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +10,512 | $10.76 | $113k | 73,927 | Dec 10, 2025 |
| Dec 8, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -42,841 | $41.49 | $1.8M | 31,086 | Dec 10, 2025 |
| Dec 8, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -16,164 | $0.00 | $0 | 5,388 | Dec 10, 2025 |
| Dec 8, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -16,165 | $0.00 | $0 | 12,123 | Dec 10, 2025 |
| Dec 8, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -10,512 | $0.00 | $0 | 14,016 | Dec 10, 2025 |
| Nov 12, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +19,900 | $30.93 | $616k | 50,986 | Nov 14, 2025 |
| Nov 12, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -19,900 | $40.94 | $815k | 31,086 | Nov 14, 2025 |
| Nov 12, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -19,900 | $0.00 | $0 | 0 | Nov 14, 2025 |
| Oct 28, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +100 | $30.93 | $3,093 | 31,186 | Oct 30, 2025 |
| Oct 28, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -100 | $41.00 | $4,100 | 31,086 | Oct 30, 2025 |
| Oct 28, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -100 | $0.00 | $0 | 19,900 | Oct 30, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +1,592 | - | - | 28,601 | Sep 3, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +1,750 | - | - | 30,351 | Sep 3, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +2,694 | - | - | 33,045 | Sep 3, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | FTax withholding Class A Ordinary Share | -2,920 | $33.49 | $98k | 30,125 | Sep 3, 2025 |
| Sep 2, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +1,861 | - | - | 31,986 | Sep 3, 2025 |
| Sep 2, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | FTax withholding Class A Ordinary Share | -900 | $34.28 | $31k | 31,086 | Sep 3, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Restricted Share Unitderivative | +12,275 | $0.00 | $0 | 12,275 | Sep 3, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Share Optionderivative | +39,363 | $0.00 | $0 | 39,363 | Sep 3, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -1,592 | $0.00 | $0 | 4,773 | Sep 3, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -1,750 | $0.00 | $0 | 3,500 | Sep 3, 2025 |
| Sep 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -2,694 | $0.00 | $0 | 2,694 | Sep 3, 2025 |
| Sep 2, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -1,861 | $0.00 | $0 | 0 | Sep 3, 2025 |
| Aug 4, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +18,889 | $22.89 | $432k | 45,898 | Aug 6, 2025 |
| Aug 4, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -18,889 | $32.89 | $621k | 27,009 | Aug 6, 2025 |
| Aug 4, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -18,889 | $0.00 | $0 | 2,036 | Aug 6, 2025 |
| Jun 3, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +18,299 | $18.00 | $329k | 45,308 | Jun 5, 2025 |
| Jun 3, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -18,299 | $28.80 | $527k | 27,009 | Jun 5, 2025 |
| Jun 3, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -18,299 | $0.00 | $0 | 0 | Jun 5, 2025 |
| May 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Performance Share Unitderivative | +4,558 | $0.00 | $0 | 4,558 | May 5, 2025 |
| May 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Performance Share Unitderivative | +4,786 | $0.00 | $0 | 4,876 | May 5, 2025 |
| May 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Performance Share Optionderivative | +7,368 | $0.00 | $0 | 7,368 | May 5, 2025 |
| May 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Performance Share Optionderivative | +7,606 | $0.00 | $0 | 7,606 | May 5, 2025 |
| Apr 29, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +20,000 | $15.52 | $310k | 47,009 | May 1, 2025 |
| Apr 29, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +22,000 | $15.50 | $341k | 69,009 | May 1, 2025 |
| Apr 29, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -42,000 | $25.61 | $1.1M | 27,009 | May 1, 2025 |
| Apr 30, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +21,254 | $16.90 | $359k | 48,263 | May 1, 2025 |
| Apr 30, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -21,254 | $26.95 | $573k | 27,009 | May 1, 2025 |
| May 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +12,000 | $17.92 | $215k | 39,009 | May 1, 2025 |
| May 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +13,141 | $17.76 | $233k | 52,150 | May 1, 2025 |
| May 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -25,141 | $27.80 | $699k | 27,009 | May 1, 2025 |
| Apr 29, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -20,000 | $0.00 | $0 | 0 | May 1, 2025 |
| Apr 29, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -22,000 | $0.00 | $0 | 0 | May 1, 2025 |
| Apr 30, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -21,254 | $0.00 | $0 | 2,471 | May 1, 2025 |
| May 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -12,000 | $0.00 | $0 | 0 | May 1, 2025 |
| May 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -13,141 | $0.00 | $0 | 28,909 | May 1, 2025 |
| Apr 26, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +990 | - | - | 27,488 | Apr 29, 2025 |
| Apr 26, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | FTax withholding Class A Ordinary Share | -479 | $21.37 | $10k | 27,009 | Apr 29, 2025 |
| Apr 26, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -990 | $0.00 | $0 | 0 | Apr 29, 2025 |
| Apr 7, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +2,694 | - | - | 27,801 | Apr 9, 2025 |
| Apr 7, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | FTax withholding Class A Ordinary Share | -1,303 | $20.28 | $26k | 26,498 | Apr 9, 2025 |
| Apr 7, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -2,694 | $0.00 | $0 | 2,694 | Apr 9, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +1,750 | - | - | 25,132 | Apr 3, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +1,592 | - | - | 26,724 | Apr 3, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | FTax withholding Class A Ordinary Share | -847 | $21.77 | $18k | 25,877 | Apr 3, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | FTax withholding Class A Ordinary Share | -770 | $21.77 | $17k | 25,107 | Apr 3, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Share Optionderivative | +29,480 | $0.00 | $0 | 29,480 | Apr 3, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Restricted Share Unitderivative | +7,382 | $0.00 | $0 | 7,382 | Apr 3, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Performance Share Unitderivative | +14,765 | $0.00 | $0 | 14,765 | Apr 3, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -1,750 | $0.00 | $0 | 3,500 | Apr 3, 2025 |
| Apr 1, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative | -1,592 | $0.00 | $0 | 4,773 | Apr 3, 2025 |
| Mar 20, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +15,944 | $12.97 | $207k | 39,326 | Mar 24, 2025 |
| Mar 20, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -15,944 | $23.11 | $368k | 23,382 | Mar 24, 2025 |
| Mar 20, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -15,944 | $0.00 | $0 | 8,374 | Mar 24, 2025 |
| Mar 16, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +872 | - | - | 23,830 | Mar 19, 2025 |
| Mar 16, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | FTax withholding Class A Ordinary Share10b5-1 | -448 | $22.61 | $10k | 23,382 | Mar 19, 2025 |
| Mar 17, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +11,464 | $12.97 | $149k | 34,846 | Mar 19, 2025 |
| Mar 17, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -11,464 | $23.10 | $265k | 23,382 | Mar 19, 2025 |
| Mar 19, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +8,879 | $12.97 | $115k | 32,261 | Mar 19, 2025 |
| Mar 19, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -8,879 | $23.10 | $205k | 23,382 | Mar 19, 2025 |
| Mar 16, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitderivative10b5-1 | -872 | $0.00 | $0 | 0 | Mar 19, 2025 |
| Mar 17, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -11,464 | $0.00 | $0 | 33,197 | Mar 19, 2025 |
| Mar 19, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -8,879 | $0.00 | $0 | 24,318 | Mar 19, 2025 |
| Mar 12, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +36,372 | $11.97 | $435k | 59,330 | Mar 14, 2025 |
| Mar 12, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -36,372 | $22.25 | $809k | 22,958 | Mar 14, 2025 |
| Mar 12, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -36,372 | $0.00 | $0 | 28,288 | Mar 14, 2025 |
| Dec 6, 2024 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +2,406 | $10.76 | $26k | 25,364 | Dec 10, 2024 |
| Dec 6, 2024 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -8,969 | $21.27 | $191k | 22,958 | Dec 10, 2024 |
| Dec 9, 2024 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +18,860 | $11.10 | $209k | 41,818 | Dec 10, 2024 |
| Dec 9, 2024 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -18,860 | $21.38 | $403k | 22,958 | Dec 10, 2024 |
| Dec 6, 2024 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -2,406 | $0.00 | $0 | 24,528 | Dec 10, 2024 |
| Dec 9, 2024 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -18,860 | $0.00 | $0 | 21,552 | Dec 10, 2024 |
| Dec 3, 2024 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +8,969 | $10.76 | $97k | 31,927 | Dec 5, 2024 |
| Dec 3, 2024 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -8,969 | $21.45 | $192k | 22,958 | Dec 5, 2024 |
| Dec 4, 2024 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +5,024 | $10.76 | $54k | 27,982 | Dec 5, 2024 |
| Dec 4, 2024 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -5,024 | $21.25 | $107k | 22,958 | Dec 5, 2024 |
| Dec 5, 2024 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +1,123 | $10.76 | $12k | 24,081 | Dec 5, 2024 |
| Dec 5, 2024 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -1,123 | $21.25 | $24k | 22,958 | Dec 5, 2024 |
| Dec 3, 2024 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -8,969 | $0.00 | $0 | 33,081 | Dec 5, 2024 |
| Dec 4, 2024 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -5,024 | $0.00 | $0 | 28,057 | Dec 5, 2024 |
| Dec 5, 2024 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -1,123 | $0.00 | $0 | 26,934 | Dec 5, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.